Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/30/2023 | 662.71% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
07/21/2023 | 577.97% | JonesTrading | → $8 | Initiates Coverage On | → Buy |
05/17/2023 | 493.22% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
05/17/2023 | 832.2% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
02/09/2023 | 493.22% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
02/09/2023 | 832.2% | Chardan Capital | → $11 | Reiterates | → Buy |
10/17/2022 | 493.22% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
09/08/2022 | 832.2% | Chardan Capital | → $11 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年08月30日 | 662.71% | HC Wainwright公司 | $7→$9 | 维护 | 买 |
07/21/2023 | 577.97% | Jones Trading | →$8 | 开始承保 | →购买 |
2023年05月17日 | 493.22% | HC Wainwright公司 | →$7 | 重申 | 购买→购买 |
2023年05月17日 | 832.2% | 查尔丹资本 | →$11 | 重申 | 购买→购买 |
02/09/2023 | 493.22% | HC Wainwright公司 | →$7 | 重申 | →购买 |
02/09/2023 | 832.2% | 查尔丹资本 | →$11 | 重申 | →购买 |
10/17/2022 | 493.22% | HC Wainwright公司 | →$7 | 开始承保 | →购买 |
09/08/2022 | 832.2% | 查尔丹资本 | →$11 | 开始承保 | →购买 |
What is the target price for Purple Biotech (PPBT)?
紫色生物科技公司(PPBT)的目标价是多少?
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by HC Wainwright & Co. on August 30, 2023. The analyst firm set a price target for $9.00 expecting PPBT to rise to within 12 months (a possible 662.71% upside). 8 analyst firms have reported ratings in the last year.
紫生物技术公司(纳斯达克代码:PPBT)的最新目标价是由HC Wainwright&Co.于2023年8月30日报道的。这家分析公司将目标价定为9美元,预计购买力平价将在12个月内上涨(可能上涨662.71%)。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Purple Biotech (PPBT)?
紫色生物科技公司(PPBT)的最新分析师评级是多少?
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.
分析师对紫色生物科技公司(纳斯达克代码:PPBT)的最新评级由HC Wainwright&Co.提供,紫色生物科技公司维持买入评级。
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
紫色生物科技(PPBT)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on August 30, 2023 so you should expect the next rating to be made available sometime around August 30, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Purple Biotech的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。紫色生物技术的上一次评级是在2023年8月30日提交的,所以你应该预计下一次评级将在2024年8月30日左右的某个时候公布。
Is the Analyst Rating Purple Biotech (PPBT) correct?
分析师对紫色生物科技(PPBT)的评级正确吗?
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $7.00 to $9.00. The current price Purple Biotech (PPBT) is trading at is $1.18, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的紫色生物技术(PPBT)评级维持不变,目标价在7.00美元至9.00美元之间。紫色生物科技(PPBT)目前的交易价格为1.18美元,超出了分析师的预测区间。